| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0753-3322(97)83541-X |
| P698 | PubMed publication ID | 9309246 |
| P50 | author | Paul J Farrell | Q38318831 |
| P2093 | author name string | Cludts I | |
| Stühler A | |||
| P2860 | cites work | Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 | Q24650743 |
| A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa | Q24682619 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. | Q33189141 | ||
| Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells | Q33929593 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene | Q35838226 | ||
| Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein | Q35854017 | ||
| Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. | Q35917481 | ||
| Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. | Q36555784 | ||
| Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts | Q36696963 | ||
| Binding and suppression of the Myc transcriptional activation domain by p107. | Q36746147 | ||
| Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 | Q36806063 | ||
| The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. | Q38301679 | ||
| Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells | Q38322174 | ||
| Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 | ||
| Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease | Q38489712 | ||
| Epstein-Barr virus immortalizing genes | Q40540784 | ||
| Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells | Q40666871 | ||
| Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease | Q40785638 | ||
| T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections | Q40787633 | ||
| EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. | Q40792597 | ||
| Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53 | Q40806210 | ||
| The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter | Q41415414 | ||
| Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region | Q44286183 | ||
| Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma | Q44939914 | ||
| Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease | Q44983123 | ||
| Epstein-Barr virus gene expression in nasopharyngeal carcinoma | Q45205828 | ||
| A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancers | Q45763326 | ||
| Epstein-Barr virus-driven gene therapy for EBV-related lymphomas | Q45766003 | ||
| Epstein-Barr virus in Hodgkin's disease patients in Japan | Q45770772 | ||
| Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 | ||
| Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection | Q45838183 | ||
| Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. | Q45841044 | ||
| An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 | ||
| Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma | Q68306620 | ||
| Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers | Q71195340 | ||
| Viruses and human cancer | Q72874732 | ||
| P433 | issue | 6-7 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 258-267 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Biomedicine and Pharmacotherapy | Q15759648 |
| P1476 | title | Epstein-Barr virus genes and cancer cells | |
| P478 | volume | 51 |
| Q33854424 | An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A |
| Q37210191 | Contributory role of viral infection in congenital tumour development |
| Q37889807 | Endoplasmic reticulum calcium pumps and cancer |
| Q33649613 | Endoplasmic reticulum calcium pumps and cancer cell differentiation |
| Q45738520 | Epstein-Barr virus detection in ductal carcinoma of the breast |
| Q34782258 | Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines |
| Q35914457 | Investigation of adenovirus occurrence in pediatric tumor entities. |
| Q36961021 | Multiple roles of TRAF3 signaling in lymphocyte function. |
| Q45743213 | No direct role for Epstein-Barr virus in oral carcinogenesis: a study at the DNA, RNA and protein levels |
| Q43471117 | No evidence of Epstein-Barr virus association with Merkel cell carcinoma |
| Q34754675 | Notch signaling as a therapeutic target |
| Q33863072 | Regulation of cell growth and death by Epstein-Barr virus |
| Q41718695 | TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1. |
| Q45751597 | The kinetics of cancer cells and of HIV1: the problems of cell and virus rebounds and of latency |
| Q89777732 | The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency |
| Q33806150 | Viruses in human cancers |
| Q73534470 | Viruses in human cancers |
Search more.